Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008-2018, and perspectives on cancer prevention.

Abstract

PURPOSE:

Three human papillomavirus (HPV) vaccines are available against up to nine HPV types. In Sweden, from 2012, Gardasil was offered to 10-12 year old girls through the school-based vaccination program, and as catchup vaccination for women up to 26 years. To obtain a baseline, and follow HPV vaccination effects, during 2008-2018, cervical and oral HPV prevalence were followed at a youth clinic in Stockholm, and in 2013 for comparison oral HPV prevalence was examined in high-school youth in a middle-sized county in Sweden.

METHODS:

In this review, we discuss all our data with cervical and oral mouthwash samples that were collected and tested for 24-27 HPV types by a bead-based multiplex assay from 2008.

RESULTS:

Compared with 2008-2011, with ~ 35% HPV16 and > 60% high risk (HR) HPV cervical prevalence at the youth clinic, a decrease of vaccine HPV types was observed between 2013 and 2018, with e.g., HPV16 falling to 5% in catchup vaccinated women and 15-18% in nonvaccinated women. Most common cervical HR-HPV types were HPV39, 51, 52, 56, and 59 together accounting for ~ 10% of cervical cancer, and where only HPV52 is included in Gardasil-9. At baseline 2009-2011, oral HPV prevalence was ~ 10% in unvaccinated youth at the youth clinic, but after 2013 it dropped to < 2% at the youth clinic and high schools.

CONCLUSION:

To conclude, Gardasil HPV types have decreased, but it is still important to follow remaining HR-HPV types and cancer development, since there is an ongoing increase in the incidence of HPV-associated tonsillar and base of tongue cancer, and cervical cancer in Sweden.

• Authors: Juan Du, Andreas Ährlund-Richter, Anders Näsman, Tina Dalianis
• Journal: Archives of gynecology and obstetrics (Arch Gynecol Obstet) Vol. 303 Issue 2 Pg. 329-335 (02 2021) ISSN: 1432-0711 [Electronic] Germany
• PMID: 33247317 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
• Human Papillomavirus Recombinant Vaccine nonavalent
• Papillomavirus Vaccines

Topics

• Adolescent
• Adult
• Alphapapillomavirus (immunology)
• Child
• Female
• Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (immunology)
• Human papillomavirus 16
• Humans
• Incidence
• Papillomaviridae (genetics, isolation & purification)
• Papillomavirus Infections (diagnosis, epidemiology, prevention & control, virology)
• Papillomavirus Vaccines (administration & dosage, adverse effects, immunology)
• Prevalence
• Sweden (epidemiology)
• Uterine Cervical Neoplasms (prevention & control, virology)
• Vaccination